The use of lacZ-transduced tumor cells enhances the sensitivity of micrometastasis detection: A comparative study of gemcitabine treatment efficacy in the mouse LM8 osteosarcoma cell model
Journal Title: Journal of Cancer Research & Therapy - Year 2014, Vol 2, Issue 6
Abstract
In osteosarcoma patients as well as in preclinical osteosarcoma animal models post-therapy detection of residual disease and of metastases in particular remains a great challenge. The therapeutic efficacy is often overestimated because disseminated tumor cells frequently persist undetectable as dormant micrometastases. This can be avoided in preclinical studies by tagging the tumor cells with reporter genes that allow their selective detection in normal tissue down to the single cell level. In the present study we made use of a lacZ reporter gene and reinvestigated the therapeutic effect of gemcitabine on subcutaneous primary tumor growth and metastasis of mouse LM8 osteosarcoma cells in syngeneic C3H mice. Furthermore we compared the sensitivity of LM8-lacZ and of non-transduced LM8 cells to gemcitabine in vitro and in vivo because it was recently demonstrated that expression of a GFP reporter gene in osteosarcoma cells altered their aggressiveness. The present study showed that, in contrast to previous reports, gemcitabine treatment did not completely eradicate metastasis although it efficiently suppressed the growth of primary tumors and macrometastases. The results also showed that minimal residual disease is not restricted to the lungs, but also occurs in the liver and the kidneys. The direct comparison of the LM8-lacZ with the LM8 cells furthermore demonstrated that constitutive expression of the lacZ reporter gene has no effect on the aggressiveness of the cells or their sensitivity to gemcitabine. The LM8-lacZ cell-derived osteosarcoma mouse model thus represents a highly sensitive and reliable model for evaluation of anticancer drug efficacy in vivo.
Authors and Affiliations
Arlt MJE, Banke IJ, Walters DK, Berndt K, Strehler EE, Born W, Fuchs B
Keywords
Related Articles
- EP ID EP547501
- DOI 10.14312/2052-4994.2014-13
- Views 74
- Downloads 0
Lichenoid mucocutaneous syndrome a variant of para neoplastic pemphigus (PNP) following the treatment of follicular non-Hodgkin’s lymphoma with fludarabine
Background: Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease associated with cancer. Since the original description of the condition, various publications have suggested the presence of a heterogeneo...
The positive sentinel lymph node biopsy- can we predict which patients will benefit from further surgery?
Introduction: Although sentinel lymph node biopsy (SLNB) is the gold standard for clinical and radiological negative axillae in breast cancer, the subsequent management of positive nodes is currently under scrutiny with...
Impact of initial time to prostate-specific antigen nadir on survival in prostate cancer with bone metastasis initially treated with maximum androgen blockade therapy
Background: The objective of this study is to provide certain data on clinical outcomes and their predictors of traditional maximum androgen blockade (MAB) in prostate cancer with bone metastasis. Methods: Subjects were...
Combined treatment of gemcitabine with indole-3-carbinol or metformin on drug efficacy in pancreatic cancer cell lines: The role of human equilibrative nucleoside transporters
Pancreatic cancer is one of the most lethal carcinomas in the United States. In accord with the American Cancer Society pancreatic cancer is anticipated to move from the third to the second leading cause of deaths in the...
In vitro and in vivo evaluation of tubulin inhibitors with non-small cell lung cancer pre-clinical models
Synthetic small molecule tubulin inhibitors have many advantages as novel anti-cancer agents compared to the current tubulin inhibitors generated from natural products. Our previous studies led to the design and synthesi...